ANIP Historical Earnings image   This ANIP historical earnings page last updated 8/10/2022
ANIP Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/8/20220.07B
Q1 20225/10/20220.06B
Q4 20213/15/20220.06B
Q3 202111/1/20210.05B
Q2 20218/6/20210.05B
Q1 20215/7/20210.05B
Q4 20203/9/20210.06B
Q3 202011/5/20200.05B
Q2 20208/6/20200.05B
Q1 20205/7/20200.05B
Q4 20192/27/20200.05B
Q3 201911/6/20190.05B
Q2 20198/7/20190.05B
Q1 20195/9/20190.05B
Q4 20182/27/201957.12M
Q3 201811/6/201850.70M
Q2 20188/7/201847.27M
Q1 20185/8/201846.48M
Q4 20172/27/201847.29M
Q3 201711/2/201748.16M
Q2 20178/3/201744.76M
Q1 20175/4/201736.63M
Q4 20163/2/201738.20M
Q3 201611/3/201638.52M
Q2 20168/4/201631.33M
Q1 20165/5/201620.55M
Q4 20152/23/201618.04M
Q3 201511/3/201519.97M
Q2 20158/4/201519.52M
Q1 20155/5/201518.80M
Q4 20142/19/201521.04M
Q3 201411/3/201417.40M
Q2 20148/4/20146.65M
Q1 20145/5/201410.90M
Q4 20132/18/201410.53M
Q3 201311/7/20137.84M
ANIP Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/8/20220.130
Q1 20225/10/2022-0.120
Q4 20213/15/20220.540
Q3 202111/1/20211.010
Q2 20218/6/20210.670
Q1 20215/7/20211.040
Q4 20203/9/20210.800
Q3 202011/5/20200.970
Q2 20208/6/20200.690
Q1 20205/7/20201.040
Q4 20192/27/20201.080
Q3 201911/6/20191.230
Q2 20198/7/20191.440
Q1 20195/9/20191.300
Q4 20182/27/20191.32
Q3 201811/6/20181.29
Q2 20188/7/20181.13
Q1 20185/8/20181.32
Q4 20172/27/20181.08
Q3 201711/2/20171.11
Q2 20178/3/20170.98
Q1 20175/4/20170.74
Q4 20163/2/20170.84
Q3 201611/3/20161.09
Q2 20168/4/20161.11
Q1 20165/5/20160.76
Q4 20152/23/20160.52
Q3 201511/3/20150.8
Q2 20158/4/20150.55
Q1 20155/5/20150.57
Q4 20142/19/20151.94
Q3 201411/3/20140.66
Q2 20148/4/2014-0.21
Q1 20145/5/20140.33
Q4 20132/18/20140.35
Q3 201311/7/20130.16
Quotes delayed 20 minutes

Email EnvelopeFree ANIP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ANI Pharmaceuticals (ANIP) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ANIX Historical Earnings
ANNX Historical Earnings
ANVS Historical Earnings
APDN Historical Earnings
APEN Historical Earnings
APLS Historical Earnings
APLT Historical Earnings
APR Historical Earnings
APRE Historical Earnings
APTX Historical Earnings
What was the record high ANIP historical earnings result?
In terms of earnings or revenue, what is the best ANIP historical earnings result that ANI Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ANIP historical earnings result was set in Q4 2014, when ANI Pharmaceuticals posted results of 1.94/share. The most successful revenue quarter within our data set was Q2 2022 when ANI Pharmaceuticals reported revenue of 0.07B.

What was the lowest ANI Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ANIP has reported, and when?

✔️Accepted answer: Within our data set, the lowest ANIP historical earnings result was set in Q2 2014, when ANI Pharmaceuticals posted results of -0.21/share. The smallest revenue quarter within our data set was Q2 2014 when ANI Pharmaceuticals reported revenue of 6.65M.

On this page we presented the ANIP historical earnings date information for ANI Pharmaceuticals. Reviewing that ANIP Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2014, when ANIP posted adjusted EPS of 1.94/share. Meanwhile the lowest ANIP historical earnings result was in Q2 2014, when ANIP posted adjusted EPS of -0.21/share. Moving to ANI Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when ANIP reported 0.07B in revenue, while the smallest revenue quarter was Q2 2014 when ANIP reported 6.65M in revenue.

For self directed investors doing their due diligence on ANIP or any other given stock, their research can benefit from looking into all of the ANI Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into ANI Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ANIP. Thanks for visiting, and the next time you need to research ANIP historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding AVO, STE Dividend Growth Rate, PZT Dividend History.

 

ANIP Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.